Evidence map›Paper›PMID 38927906›Full record

ArticleCancers2024

AI Applied to Volatile Organic Compound (VOC) Profiles from Exhaled Breath Air for Early Detection of Lung Cancer.

Manuel Vinhas, Pedro M Leitão, Bernardo S Raimundo, Nuno Gil, Pedro D Vaz, Fernando Luis-Ferreira

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Rapid Identification of Carbapenem-ResistantInfection and drug resistance · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Manuel VinhasDepartamento de Engenharia Electrotécnica e de Computadores, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Monte da Caparica, Portugal.ORCID 0009-0001-7467-1339
Pedro M LeitãoUnidade de Pulmão, Centro Clínico Champalimaud, Fundação Champalimaud, Av. Brasília, 1400-038 Lisbon, Portugal.ORCID 0009-0001-6358-9997
Bernardo S RaimundoUnidade de Pulmão, Centro Clínico Champalimaud, Fundação Champalimaud, Av. Brasília, 1400-038 Lisbon, Portugal.ORCID 0000-0001-8154-3872
Nuno GilUnidade de Pulmão, Centro Clínico Champalimaud, Fundação Champalimaud, Av. Brasília, 1400-038 Lisbon, Portugal.ORCID 0000-0002-6567-8379
Pedro D VazUnidade de Pulmão, Centro Clínico Champalimaud, Fundação Champalimaud, Av. Brasília, 1400-038 Lisbon, Portugal.ORCID 0000-0001-9720-9801
Fernando Luis-FerreiraDepartamento de Engenharia Electrotécnica e de Computadores, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Monte da Caparica, Portugal.ORCID 0000-0001-9220-6046

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Volatile organic compounds (VOCs) are an increasingly meaningful method for the early detection of various types of cancers, including lung cancer, through non-invasive methods. Traditional cancer detection techniques such as biopsies, imaging, and blood tests, though effective, often involve invasive procedures or are costly, time consuming, and painful. Recent advancements in technology have led to the exploration of VOC detection as a promising non-invasive and comfortable alternative. VOCs are organic chemicals that have a high vapor pressure at room temperature, making them readily detectable in breath, urine, and skin. The present study leverages artificial intelligence (AI) and machine learning algorithms to enhance classification accuracy and efficiency in detecting lung cancer through VOC analysis collected from exhaled breath air. Unlike other studies that primarily focus on identifying specific compounds, this study takes an agnostic approach, maximizing detection efficiency over the identification of specific compounds focusing on the overall compositional profiles and their differences across groups of patients. The results reported hereby uphold the potential of AI-driven techniques in revolutionizing early cancer detection methodologies towards their implementation in a clinical setting.

Indexed as

artificial intelligenceearly detectionlung cancermachine learningvolatile organic compounds

Identifiers

PMID38927906
PMCPMC11201396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.